Theravance Biopharma (NASDAQ:TBPH) Downgraded to “Hold” at Leerink Partnrs
Leerink Partnrs lowered shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a strong-buy rating to a hold rating in a research note released on Tuesday morning, Zacks.com reports. Several other equities analysts have also issued reports on the company. HC Wainwright decreased their price target on Theravance Biopharma from $20.00 to $15.00 and set […]
More Stories
StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)
StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Thursday. The firm...
Athersys (NASDAQ:ATHX) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note published on Thursday. The firm...
RLI (NYSE:RLI) Shares Scheduled to Split on Thursday, January 16th
Shares of RLI Corp. (NYSE:RLI – Free Report) are set to split on Thursday, January 16th. The 2-1 split was...
Martin Marietta Materials (NYSE:MLM) Rating Increased to Hold at StockNews.com
StockNews.com upgraded shares of Martin Marietta Materials (NYSE:MLM – Free Report) from a sell rating to a hold rating in...
Landmark Bancorp (NASDAQ:LARK) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Landmark Bancorp (NASDAQ:LARK – Free Report) in a research note released on Thursday. The...
Tripadvisor (NASDAQ:TRIP) Downgraded by StockNews.com to Hold
StockNews.com cut shares of Tripadvisor (NASDAQ:TRIP – Free Report) from a buy rating to a hold rating in a research...